Cognitive impairment in multiple sclerosis;Zaburzenia funkcji poznawczych w stwardnieniu rozsianym

Neurologia i Neurochirurgia Polska

Volumn 39, Issue 2, 2005, Pages 125-133

  Karlińska, Iwona ^a   Selmaj, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cognitive function; Magnetic resonance imaging (MRI); Multiple sclerosis

Indexed keywords

ATTENTION; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN TISSUE; COGNITIVE DEFECT; COMORBIDITY; COMPREHENSION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; HUMAN; INFORMATION PROCESSING; MEMORY CONSOLIDATION; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PATIENT CARE; PHYSICAL DISABILITY; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGIC TEST; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ATROPHY; BRAIN; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 18644379921     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. O'Connor P. Canadian Multiple Sclerosis Working Group. Key issues in the diagnosis and treatment of multiple sclerosis. Neurology 2002; 59: 1-33.
2. Cendrowski W. Stwardnienie rozsiane. PZWL, Warszawa 1993.
3. Mirowska D., Członkowska A. Uszkodzenie aksonów w patogenezie stwardnienia rozsianego. Neurol Neurochir Pol 2002; 36: 777-789.
4. Basso M.R., Beason-Hazen S., Lynn J. i wsp. Screening for cognitive dysfunction in multiple sclerosis. Arch Neurol 1996; 53: 980-984.
5. Amato M.P., Zipoli V. Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence. Int MSJ 2003; 10: 72-83.
6. Feinstein A. Neuropsychological dysfunction in multiple sclerosis. MS Journal 1995; 2: 61-67.
7. Rao S.M., Leo G.J., Bernardin L. i wsp. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction. Neurology 1991; 41: 685-691.
8. Ron M.A., Callanan M. Cognitive abnormalities in MS: a psychometric and MRI study. Psychol Med 1991; 21: 59-68.
9. Thornton A.E., Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 1997; 3: 357-366.
10. De Luca J., Barbieri-Berger S., Johnson S.K. The nature of memory impairment in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 1994; 16: 183-185.
11. Szepietowska E.M. Zaburzenia w funkcjonowaniu poznawczym chorych na stwardnienie rozsiane. W: Herzyk A., Kadzielawa D. [red.]. Zwiazek mózg-zachowanie w ujeciu neuropsychologii klinicznej. Wyd. UMCS, Lublin 1997.
12. Beatty W., Monson M. Metamemory in MS. J Clin Exp Neuropsychol 1991; 13: 309-327.
13. Jennekens-Schinkel A., Lanser J., van der Valde E.A. i wsp. Neuropsychological assessment in patients with multiple sclerosis and mild functional impairment. J Neurol Neurosurg Psychiatry 1991; 54: 757-762.
14. Honig L.S., Ramsay R.E., Sheremata W.A. Event-related potential P-300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment. Arch Neurol 1992; 49: 44-50.
15. Plohmann A.M., Kappos L., Ammann W. Computer assisted retraining of attentional impairment in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64: 455-462.
16. Lyon-Caen O., Jouvent R., Hauser S. i wsp. Cognitive function in recent-onset demyelinating disease. Arch Neurol 1986; 43: 1138-1141.
17. Arnett P.A., Rao S.M., Bernardin L. i wsp. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994; 44: 420-425.
18. Foong J., Rozewicz I., Quaghebeur G. i wsp. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 1997; 120: 15-26.
19. Rao S.M., Hommke T.A., Speech T.J., Wisconsin Card Sorting Test performance in relapsing-remitting and chronic progressive multiple sclerosis. J Consult Clin Psychol 1987; 55: 263-265.
20. Huijbregts S.C., Kalkers N.F., de Sonneville L.M. i wsp. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 27: 335-339.
21. Marsh G. Disability and intellectual function in multiple sclerosis patients. J Nerv Ment Dis 1980; 168: 758-762.
22. Rudick R., Antel J., Confavreux C. i wsp. Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996; 40: 469-479.
23. Vickrey B., Hays R., Harooni R. i wsp. A health-related quality of life measure for multiple sclerosis. Qual Life Research 1995; 4: 187-206.
24. Ware J., Sherbourne C. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
25. Cutajar R., Ferriani E., Scandellari C. i wsp. Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol 2000; 6: 186-190.
26. Sailer M., Heinze H.J., Schoenfeld M.A. i wsp. Amantadine influences cognitive processing in patients with multiple sclerosis. Pharmacopsychiatry 2000; 33: 28-37.
27. Oliveri R.L., Sibilia G., Valentino P. i wsp. Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand 1998; 97: 366-369.
28. Pliskin N.H., Hamer D.P., Goldstein D.S. i wsp. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 1996; 47: 1463-1468.
29. Barak Y., Achiron A. Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 2002; 47: 11-14.
30. Fischer J.S., Priore R.L., Jacobs L.D. i wsp. Neuropsychological effects of interferon beta 1-a in relapsing multiple sclerosis. Ann Neurol 2000; 48: 885-892.
31. Weinstein A., Schwid S.I., Schiffer R.B. i wsp. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999; 56: 319-324.
32. Krupp L.B., Christodoulou C., Melville P. i wsp. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585.
33. Ruggieri R.M., Palermo R., Vitello G. i wsp. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS
34. Feinstein A., Ron M., Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 1993; 116: 569-602.
35. Kujala P., Portin R., Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-years follow-up. Brain 1997; 120: 289-297.
36. Amato M.P., Ponziani G., Siracusa G. i wsp. Cognitive dysfunction in early-onset multiple sclerosis; a reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606.
37. Pozzilli C., Passafiume D., Bemardi S. Anatomical and functional correlate of cognitive deficit in multiple sclerosis. J Neurol Sci 1993; 115 (Suppl.): 55-58.
38. Hohol M.J., Guttman C.R., Orav J. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple scerosis. Arch Neurol 1997; 54: 1018-1025.
39. Foong J., Rozewicz L., Quanghebeur G. i wsp. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 1998; 64: 529-532.
40. Swirsky-Sacchetti T., Mitchell D., Seward J. i wsp. Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis. Neurology 1992; 42: 1291-1295.
41. Modestowicz R., Sosnowski P., Wender M. i wsp. Morfologia ognisk demielinizacyjnych a zaburzenia funkcji poznawczych i emocjonalnych u chorych na stwardnienie rozsiane. Neurol Neurochir Pol 2000; 34: 23-33.
42. Filippi M., Tortorella C., Rovatis M. i wsp. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68: 157-161.
43. Rovaris M., Filippi M. MRI correlates of cognitive dysfunction in multiple sclerosis patients. J Neurovirol 2000; 6: 172-175.
44. Rovaris M., Filippi M., Falautano M. i wsp. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50: 1601-1608.
45. Benedict R.H., Carone D.A., Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004; 14 (3 Suppl.): 36-45.
46. Zivadinov R., De Masi R., Nasueli D. i wsp. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001; 43: 272-278.
47. Benedict R., Weinstock-Guttman B., Fishman I. i wsp. Prediction of neuropsychological impairment in multiple sclerosis. Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61: 226-230.
48. Dalton C.M., Chard D.T., Davies G.R. i wsp. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101-1107.
49. Amato M.P., Bartolozzi M.L., Zipoli V. i wsp. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004; 13: 89-93.
50. Staffen W., Mair A., Zauner H. i wsp. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compesatory cortical activation during an attention task. Brain 2002; 125: 1275-1282.
51. Wishart H.A. Saykin A.J., McDonald B.C. i wsp. Brain activation patterns associated with working memory in relapsing-remitting MS. Neurology 2004; 62: 234-238.
52. Rao S.M., Bernardin L., Leo G. Cerebral disconnection in multiple sclerosis: relationship to atrophy of the Corpus Callosum. Arch Neurol 1989; 46: 918-920.
53. Bakshi R., Benedict R.H, Bermel R.A. i wsp. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62-68.
54. Blinkenberg M., Rune K., Jensen C.V. i wsp. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 2000; 54: 558-564.
55. Filley C.M. The behavioral neurology of cerebral white matter. Neurology 1998; 50: 1535-1540.